Mr. Flaherty has served as a Behrman Capital Operating Partner since March 2009. He currently serves on the Board of Emmes Corporation. Mr. Flaherty has more than 35 years of operating experience in the healthcare field, with particular expertise in the clinical laboratory environment. Previously, he was President and CEO of Athena Diagnostics, a Behrman Capital portfolio company which was sold to Fisher Scientific after three years. Prior to joining Athena, he held a series of senior management positions at Becton Dickinson & Company, a multinational medical technology company, serving as President of Becton Dickinson Medical from 1984 through 1992.